Your browser doesn't support javascript.
loading
Access to innovation through clinical trials and the national early access program for patients with lung cancer in France: focus on atezolizumab and durvalumab.
Jacquet, Emmanuelle; Pham, Fiona; Taouk, Billy; Kerouani-Lafaye, Ghania; Monard, Adrien; Brunel, Liora; Albin, Nicolas.
  • Jacquet E; Department of Oncohematology, Centre Hospitalier Universitaire Grenoble-Alpes, Grenoble, France.
  • Pham F; Oncology Hematology and Cell Therapy Department, French National Agency for Safety of Medicines and Health Products ANSM, 147 Boulevard Anatole France, Saint-Denis, France.
  • Taouk B; Department of Pharmacy, Centre Hospitalo-Universitaire Hôpital Henri Mondor Assistance Publique des Hôpitaux de Paris, Créteil, France.
  • Kerouani-Lafaye G; Oncology Hematology and Cell Therapy Department, French National Agency for Safety of Medicines and Health Products ANSM, 147 Boulevard Anatole France, Saint-Denis, France.
  • Monard A; Oncology Hematology and Cell Therapy Department, French National Agency for Safety of Medicines and Health Products ANSM, 147 Boulevard Anatole France, Saint-Denis, France.
  • Brunel L; Oncology Hematology and Cell Therapy Department, French National Agency for Safety of Medicines and Health Products ANSM, 147 Boulevard Anatole France, Saint-Denis, France.
  • Albin N; Department of Oncohematology, Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France.
Cancer Chemother Pharmacol ; 92(3): 223-228, 2023 09.
Article en En | MEDLINE | ID: mdl-37439816
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Pulmonares Límite: Humans País como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Pulmonares Límite: Humans País como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article